COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,677 Articles (22,913 medRxiv, 8,764 bioRxiv)

Most recent first Previous |  Page 2250: Articles 22491-22500  | Next

Causal Analysis of Health Interventions and Environments for Influencing the Spread of COVID-19 in the United States of America
Li, z., Xu, T., Zhang, K., Deng, H.-W., Boerwinkle, E., Xiong, M.
10.1101/2020.09.29.20203505 — Posted: 2020-09-29
Predictive Modelling of COVID-19 New Cases in Algeria using An Extreme Learning Machines (ELM)
Djeddou, M., A. Hameed, I., Nejatian, A., Loukam, I.
10.1101/2020.09.28.20203299 — Posted: 2020-09-29
Analysis of the COVID-19 pandemic in Bavaria: adjusting for misclassification
Guenther, F., Bender, A., Höhle, M., Wildner, M., Küchenhoff, H.
10.1101/2020.09.29.20203877 — Posted: 2020-09-29
Brief communication: A meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19
Garcia-Albeniz, X., Del Amo, J., Polo, R., Morales Asencio, J. M., Hernan, M. A.
10.1101/2020.09.29.20203869 — Posted: 2020-09-29 Discussion: Onsite | Offsite
De Novo Discovery of High Affinity Peptide Binders for the SARS-CoV-2 Spike Protein
Pomplun, S., Jbara, M., Quartararo, A. J., Zhang, G., Brown, J. S., Lee, Y.-C., Ye, X., Hanna, S., Pentelute, B. L.
10.1101/2020.09.29.317131 — Posted: 2020-09-29
Changes to the sebum lipidome upon COVID-19 infection observed via non-invasive and rapid sampling from the skin
Spick, M. P., Longman, K., Frampas, C., Costa, C., Dunn-Walters, D., Stewart, A., Wilde, M., Greener, D., Evetts, G., Trivedi, D. K., Barran, P., Pitt, A., Bailey, M.
10.1101/2020.09.29.20203745 — Posted: 2020-09-29
Comparison of infection control strategies to reduce COVID-19 outbreaks in homeless shelters in the United States: a simulation study
Chapman, L. A. C., Kushel, M., Cox, S. N., Scarborough, A., Cawley, C., Nguyen, T., Rodriguez-Barraquer, I., Greenhouse, B., Imbert, E., Lo, N. C.
10.1101/2020.09.28.20203166 — Posted: 2020-09-29 Discussion: Onsite | Offsite
Coding Complete Genome Sequences of Twenty-three SARS-CoV-2 Strains Isolated in the Philippines
Velasco, J. S., Chinnawirotpisan, P., Joonlasak, K., Manasatienkij, W., Huang, A., Valderama, M.. T., Diones, P. C., Leonardia, S., Timbol, M. L., Navarro, F. C., Villa, V., Tabinas, H., Chua, D., Fernandez, S., Jones, A., Klungthong, C.
10.1101/2020.09.29.20203695 — Posted: 2020-09-29
Seroprevalence of SARS CoV-2 antibodies in healthcare workers and administration employees: a prospective surveillance study at a 1,400-bed university hospital in Germany
Bahrs, C., Kimmig, A., Weis, S., Ankert, J., Hagel, S., Maschmann, J., Stallmach, A., Steiner, A., Bauer, M., Behrigner, W., Baier, M., Kesselmeier, M., Richert, C., Zepf, F., Walter, M., Scherag, A., Kiehntopf, M., Loeffler, B., Pletz, M. W.
10.1101/2020.09.29.20203737 — Posted: 2020-09-29
Impact of stopping therapy during the SARS-CoV-2 pandemic in persons with lymphoma
Yang, S., Dong, D., Gu, H., Gale, R. P., Ma, J., Huang, X.
10.1101/2020.09.28.20203083 — Posted: 2020-09-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).